Article Text

PDF
Strong association between plasma thrombomodulin and pathergy test in Behçet disease
  1. S Menashi1,
  2. B Tribout2,
  3. C Dosquet3,
  4. P Le Toumelin4,
  5. J-C Piette5,
  6. B Wechsler5,
  7. M-C Boffa5
  1. 1
    Laboratoire CRRET, CNRS UMR 7149, Université Paris 12, Créteil, France
  2. 2
    Service de Médecine Vasculaire, CHU Amiens, France
  3. 3
    Unité de Thérapie Cellulaire et Clinique Transfusionnelle, AP-HP, Hôpital Saint-Louis, Paris, France
  4. 4
    Department of Public Health, AP-HP, Hôpital Avicenne, Bobigny, France
  5. 5
    Department of Internal Medicine, AP-HP, Hôpital Pitié-Salpêtrière, 75651 Paris, France
  1. Dr Suzanne Menashi, Laboratoire CRRET, CNRS UMR 7149, Université Paris 12, 61 Ave du Général de Gaulle, 94010 Créteil Cedex, France; menashi{at}univ-paris12.fr

Statistics from Altmetric.com

Behçet disease (BD) is a chronic systemic auto-inflammatory immune disorder with generalised vasculitis of the arteries and veins. It was originally described as orogenital aphthous ulcerations and uveitis but the disease can affect any organ or system. BD is characterised by recurrent crises of variable duration and intervals. The skin pathergy reaction (SPR),1 which explores hypersensitivity to minor trauma (needle prick), is considered as one of the main criteria for BD diagnosis, by both the International Study Group (ISG) of BD and the Behçet Disease Japanese Committee.2 In spite of its high specificity, SPR has a variable sensitivity and inconstant reproducibility, which limit its use.

Although the aetiology of the disease is still unknown, …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.